The leadership of Turkey’s newest major pharmaceutical player, Pharmactive, discuss the firm’s two pronged growth strategy, detailing their own sales objectives and prospects, as well as the opportunities that they…
Interview: Gilles Renacco – General Manager, Servier Turkey
Gilles Renacco, the recently appointed general manager of Servier Turkey, provides insights into the successful localization process pioneered by Servier in the country, where 98 percent of the company’s products…
Interview: Christopher Gaunt Chairman – British Chamber of Commerce in…
Christopher Gaunt, chairman of the British Chamber of Commerce in Turkey, analyzes the relationship between the two countries and the ongoing development of their relationship, in addition to how UK…
Interview: Bahadir Kaleagasi – Secretary General, Turkish Industry &…
Bahadir Kaleagasi, secretary general of the Turkish Industry & Business Association [TÜSIAD] discusses the strengths of the country as Europe’s gateway to Asia in addition to the strong investment landscape…
Interview: Murat Üçer – Consultant, Global Source Partners; Co-Founder,…
Murat Üçer, reputed macroeconomist, former advisor to the Ministry of Economy, Global Source Partners’ consultant in Turkey, co-founder of Turkey Data Monitor, and senior lecturer at Koç University, dissects the…
Interview: Uğur Baran – General Secretary, OHSAD, Turkey
Dr. Uğur Baran, general secretary of OHSAD – Turkey’s Private Hospital and Health Organizations Association – highlights how he is striving to keep open the dialogue between the association and…
Interview: Ümit Dereli – Secretary General and Cengiz Aydın –…
Dr. Ümit Dereli and Cengiz Aydın of the Association of Research-Based Pharmaceutical Companies [AIFD] inTurkey discuss significant recent changes in the Turkish ecosystem, including the improving recognition of the country’s regulatory…
Top 100 Pharma Companies Ranking in Turkey
Below is a list of the Top 100 Pharma Companies in Turkey sorted by the total value of sales in USD for 2014. Global giant Novartis is number one in…
Why Invest in the Turkish Pharmaceutical Market?
Despite a current lack of investment incentives; Turkey’s geographical location, market size, large and aging population, universal healthcare, potential future spending, and stage of economic development mean that it is…
A Framework for R&D Investment and Innovation in Turkey
Although the Turkish pharmaceutical market has grown significantly in recent years R&D investment remains comparatively low. However, the expertise and capabilities exist for growth in this sector. Turkish companies and…
A New Era for Turkish Healthcare
In the first fifteen years of the 21st century Turkey saw rapid economic growth, greater access to healthcare, and a boom in pharmaceutical sales. The country’s healthcare sector is now…
Interview: Tugce Gozacan, Owner & Okan Gozacan, Chairman, Marmara Ecza,…
Tugce Gozacan [pictured] and Okan Gozacan, Owner and Chairman of Marmara Ecza respectively, discuss what qualities are crucial for suppliers in the pharmaceutical industry, their process for forming partnerships and…
Interview: Ersan Kuçuk – General Manager, Drogsan, Turkey
The general manager of Drogsan, Ersan Kuçuk elaborates on the company’s efforts in shifting towards more value-added pharmaceutical products, specifically within the realm of biosimilars, while highlighting his ambitions in…
Abdi İbrahim, the Turkish pharmaceutical industry leader, was founded at a small pharmacy in 1912 in Küçükmustafapaşa, Istanbul, by pharmacist Abdi İbrahim Bey. Abdi İbrahim has the largest product portfolio in the sector, with nearly 200 brands and more than 400 products which it develops itself as well as working with 30 licensors.
With its powerful vision, dynamic structure and contemporary outlook, Abdi İbrahim has been the leader of Turkey’s pharmaceutical industry since 2002. Today, Abdi İbrahim, which operates in 14 countries outside Turkey, exports to more than 60 countries ranging from Canada to European Union member states, from North Africa to Asia, and is the largest employer in the Turkish pharmaceutical industry with 4.600 qualified employees. The company also leads with its marketing and sales team, which is the largest in the industry.
Abdi İbrahim, which has the first accredited R&D centre in the industry, is a role model with its technological equipment and architecture as well as its R&D processes for future healthcare.
As well as its R&D Centre, Abdi İbrahim has a manufacturing facility for chemical products, Turkey's largest biotechnological manufacturing facility AbdiBio, a hormone production facility, a sterile ophthalmology and sterile inhalation products production facility, and a sterile injectable and oncology products production facility which will be operational in 2023 in Istanbul’s Esenyurt production complex. Abdi İbrahim has also R&D centres and production facilities in Kazakhstan and Algeria.
Abdi İbrahim was part of the Swiss joint venture that acquired OM Pharma, an 83-year-old pharma company based in Switzerland, one of the leading countries in the pharmaceutical industry, in 2020. After the acquisition, Abdi İbrahim owned a 28.5 percent stake in OM Pharma. The acquisition made Abdi İbrahim the first and only Turkish pharma company to form a strategic partnership with a European counterpart. Abdi İbrahim was also the only foreign partner in the joint venture that acquired OM Pharma. Abdi İbrahim has added to its investments with the acquisition of a 90% share of INOLIVA, a company operating in the Turkish health sector that has rapidly made its mark on the market with its innovative products.
With its “Rational Medicine Use Campaign”, initiated in its 100th year of operation, Abdi İbrahim aims to raise social awareness and achieve long term behavioural change in unconscious medicine use, which has a high impact on public health and the country’s economy.
In 2015, Abdi İbrahim renovated the health museum in Dar al-Shifa’, focusing on Ottoman medicine from the 15th to the 18th century, making the treasures of our medical history accessible to the public. The Sultan Bayezid II Edirne Hospital Restoration Project has been achieved 6 awards.
Abdi İbrahim took an important step by signing United Nations Global Principles Agreement in 2010, creating the opportunity to share the high standards which it has achieved in the fields of human rights and environmental and social responsibility. Abdi İbrahim has also focused on its sustainability activities through Level A of the Global Reporting Initiative.
As a corporate citizen working towards creating a better world and a better future, adhering to its mission in the sector and to the requirements of societal priorities, Abdi İbrahim focuses on sustainability in all its business processes. Approaching all of its actions from the standpoint of environmental, social and governance [ESG] criteria, Abdi İbrahim has made it possible to gauge the company’s performance not only on the basis of positive financial results, but also from the perspective of its positive impact on the community and the environment.
Stepping forward in the area of maintaining sustainability as a part of its process of green transformation, Abdi İbrahim upholds the European Green Deal and the Sustainable Development Goals [SDGs] adopted by the United Nations, and also relies upon processes such as Corporate Prioritization Analysis and Organizational Life Cycle Analysis [O-LCA] to achieve improvements in all its business processes in the light of its many sustainability projects.
As from 2020, Abdi İbrahim became the first pharmaceuticals company in Turkey to use 100 percent renewable energy, with solar and wind energy plants that meet the energy needs of all its facilities and buildings. Making significant strides to reduce its carbon footprint, Abdi İbrahim’s goal is to become a carbon neutral company by 2030.
Placing great importance on the matter of water sustainability, Abdi İbrahim is the first Turkish pharmaceuticals company to join the signatories of the CEO Water Mandate, an initiative of the United Nations Global Compact. Becoming the first Turkish company to sign the ‘Science-based Targets Initiative [SBTI]’ and the first and only Turkish company to align with the Recover Better Declaration founded under the leadership of the SBTI. Abdi İbrahim has also added to this prestige by becoming a member of the Carbon Disclosure Project [CDP]. In its first reporting in the context of Climate Change and Water Safety Programmes, the company has earned eligibility to join the B- list of companies with above average global performance.
A force for healing in a changing world, Abdi İbrahim increases its effectiveness in international markets with each passing day. Its vision for 2025 - apart from maintaining its status as a wholly local company - is to become "one of the top 100 pharmaceutical companies in the world".
What is the top pharma company in Turkey?
Pharmaceutical companies As for the domestic companies in the sector, Abdi İbrahim İlaç Sanayi ve Tic A. Ş. was by far the leading manufacturer, with its net sales exceeding 4.9 million Turkish lira in 2021. Ranking second, Koçak Farma İlaç ve Kimya Sanayi A.nullPharmaceutical industry in Turkey - statistics & facts - Statistawww.statista.com › topics › pharmaceutical-industry-in-turkeynull
How many pharmaceutical companies are there in Turkey?
Turkish pharmaceutical industry comprises approximately 785 companies, 96 pharmaceutical and radiopharmaceutical manufacturers that operate at international standards, and 12 raw material production facilities.nullturkish pharmaceutical industrywww.ieis.org.tr › pdf › 5822m1wt_turkish-pharmaceutical-market-2021null
Which are the top 10 pharma companies?
Top 10 Pharma Companies By Market Cap In India.
Sun Pharmaceutical Industries Ltd. ... .
Cipla Ltd. ... .
Dr Reddy's Laboratories Ltd. ... .
Mankind Pharma Ltd. ... .
Torrent Pharmaceuticals Ltd. ... .
Zydus Lifesciences Ltd. ... .
Lupin Ltd. ... .
Alkem Laboratories Ltd..
Who is the manufacturer of generic drugs in Turkey?
EastPharma is a pharmaceutical company specialising in the manufacturing and marketing of branded and in-licensed generic pharmaceuticals in Turkey and other regional markets.nullEastpharmawww.eastpharmaltd.comnull